• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Key Highlights of the Canadian Thoracic Society's Position Statement on the Optimization of COPD Management During the Coronavirus Disease 2019 Pandemic.

作者信息

Bhutani Mohit, Hernandez Paul, Bourbeau Jean, Dechman Gail, Penz Erika, Aceron Raymond, Beauchamp Marla, Wald Joshua, Stickland Michael, Olsen Sharla-Rae, Goodridge Donna

机构信息

Division of Pulmonary Medicine, Department of Medicine, University of Alberta, Edmonton, AB, Canada.

Department of Medicine, Dalhousie University, Halifax, NS, Canada.

出版信息

Chest. 2020 Sep;158(3):869-872. doi: 10.1016/j.chest.2020.05.530. Epub 2020 May 16.

DOI:10.1016/j.chest.2020.05.530
PMID:32422130
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7228892/
Abstract
摘要

相似文献

1
Key Highlights of the Canadian Thoracic Society's Position Statement on the Optimization of COPD Management During the Coronavirus Disease 2019 Pandemic.加拿大胸科学会关于2019年冠状病毒病大流行期间慢性阻塞性肺疾病管理优化的立场声明要点
Chest. 2020 Sep;158(3):869-872. doi: 10.1016/j.chest.2020.05.530. Epub 2020 May 16.
2
Key Highlights From the Canadian Thoracic Society's Position Statement on Optimizing the Management of Sleep Disordered Breathing During the Coronavirus Disease 2019 Pandemic.加拿大胸科学会关于优化2019冠状病毒病大流行期间睡眠呼吸障碍管理的立场声明的关键要点。
Chest. 2020 Sep;158(3):899-900. doi: 10.1016/j.chest.2020.05.572. Epub 2020 Jun 6.
3
Concerns About Coronavirus Disease-Related Collateral Damage for Patients With COPD.对慢性阻塞性肺疾病患者与冠状病毒病相关附带损害的担忧。
Chest. 2020 Sep;158(3):866-868. doi: 10.1016/j.chest.2020.05.549. Epub 2020 May 28.
4
Key Highlights From the Canadian Thoracic Society Position Statement on the Optimization of Asthma Management During the Coronavirus Disease 2019 Pandemic.加拿大胸科学会关于2019冠状病毒病大流行期间哮喘管理优化的立场声明要点
Chest. 2020 Oct;158(4):1335-1337. doi: 10.1016/j.chest.2020.05.551. Epub 2020 May 28.
5
[Asthma and COPD management during the COVID-19 pandemic].[COVID-19大流行期间的哮喘与慢性阻塞性肺疾病管理]
Rev Med Suisse. 2020 May 6;16(692):933-938.
6
Saudi Epilepsy Society consensus on epilepsy management during the COVID-19 Pandemic.沙特癫痫协会关于COVID-19大流行期间癫痫管理的共识
Neurosciences (Riyadh). 2020 Jul;25(3):222-225. doi: 10.17712/nsj.2020.3.20200066.
7
[Medical management and prevention instruction of chronic obstructive pulmonary disease during the coronavirus disease 2019 epidemic].[2019冠状病毒病流行期间慢性阻塞性肺疾病的医疗管理与预防指导]
Zhonghua Jie He He Hu Xi Za Zhi. 2020 May 12;43(5):421-426. doi: 10.3760/cma.j.cn112147-20200227-00201.
8
Covid-19 and COPD: A Personal Reflection.新冠病毒与慢性阻塞性肺疾病：个人反思
Int J Chron Obstruct Pulmon Dis. 2020 Apr 24;15:883-884. doi: 10.2147/COPD.S255101. eCollection 2020.
9
Management of acute myocardial infarction during the COVID-19 pandemic: A Consensus Statement from the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP).COVID-19 大流行期间急性心肌梗死的管理：心血管血管造影和介入学会（SCAI）、美国心脏病学会（ACC）和美国急诊医师学会（ACEP）的共识声明。
Catheter Cardiovasc Interv. 2020 Aug;96(2):336-345. doi: 10.1002/ccd.28946. Epub 2020 May 13.
10
COVID-19 Board: Our Multidisciplinary Cutaneous Oncology Tumor Board During the Coronavirus-19 Pandemic.COVID-19 病例讨论会：新冠疫情期间我们的多学科皮肤肿瘤病例讨论会
Dermatol Surg. 2020 Sep;46(9):1224-1225. doi: 10.1097/DSS.0000000000002568.

引用本文的文献

1
Healthcare utilization trends in adults with asthma or COPD during the first year of COVID-19 pandemic in comparison to pre-pandemic: A population-based study.与疫情前相比，新冠疫情第一年成人哮喘或慢性阻塞性肺疾病患者的医疗保健利用趋势：一项基于人群的研究。
PLoS One. 2025 Mar 6;20(3):e0316553. doi: 10.1371/journal.pone.0316553. eCollection 2025.
2
An Analysis of Coronavirus Disease 2019 Infection-Related Characteristics of Chronic Obstructive Pulmonary Disease Patients with and without Inhaler Training: A Case-Control Study.2019冠状病毒病感染相关特征分析：有无吸入器训练的慢性阻塞性肺疾病患者的病例对照研究
Thorac Res Pract. 2023 Jul;24(4):186-193. doi: 10.5152/ThoracResPract.2023.22114.
3
Patient's treatment burden related to care coordination in the field of respiratory diseases.患者在呼吸系统疾病领域与护理协调相关的治疗负担。
Breathe (Sheff). 2021 Mar;17(1):210006. doi: 10.1183/20734735.0006-2021.
4
The Impact of COVID-19 on Hospitalised COPD Exacerbations in Malta.新冠疫情对马耳他住院 COPD 加重的影响。
Pulm Med. 2021 Jun 23;2021:5533123. doi: 10.1155/2021/5533123. eCollection 2021.
5
Guidance for nebulization during the COVID-19 pandemic.2019冠状病毒病大流行期间雾化治疗指南。
Lung India. 2021 Mar;38(Supplement):S86-S91. doi: 10.4103/lungindia.lungindia_681_20.
6
Clinical Characteristics and Prognosis of COPD Patients Hospitalized with SARS-CoV-2.感染新型冠状病毒肺炎住院的慢性阻塞性肺疾病患者的临床特征及预后
Int J Chron Obstruct Pulmon Dis. 2021 Jan 5;15:3433-3445. doi: 10.2147/COPD.S276692. eCollection 2020.
7
Pulmonary Rehabilitation in COVID-19 patients: A scoping review of current practice and its application during the pandemic.新冠肺炎患者的肺康复：当前实践及其在疫情期间应用的范围综述
Turk J Phys Med Rehabil. 2020 Nov 9;66(4):480-494. doi: 10.5606/tftrd.2020.6889. eCollection 2020 Dec.

本文引用的文献

1
Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19).慢性阻塞性肺疾病与严重的2019冠状病毒病（COVID-19）相关。
Respir Med. 2020 Jun;167:105941. doi: 10.1016/j.rmed.2020.105941. Epub 2020 Mar 24.
2
Clinical Characteristics of Covid-19 in New York City.纽约市新冠肺炎的临床特征
N Engl J Med. 2020 Jun 11;382(24):2372-2374. doi: 10.1056/NEJMc2010419. Epub 2020 Apr 17.
3
The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis.COPD 和吸烟史对 COVID-19 严重程度的影响：系统评价和荟萃分析。
J Med Virol. 2020 Oct;92(10):1915-1921. doi: 10.1002/jmv.25889. Epub 2020 May 17.
4
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.中国 COVID-19 患者 1590 例的合并症及其影响：一项全国性分析。
Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.00547-2020. Print 2020 May.
5
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.与严重急性呼吸综合征冠状病毒1（SARS-CoV-1）相比，严重急性呼吸综合征冠状病毒2（SARS-CoV-2）在气溶胶和表面的稳定性
N Engl J Med. 2020 Apr 16;382(16):1564-1567. doi: 10.1056/NEJMc2004973. Epub 2020 Mar 17.
6
Report on the Epidemiological Features of Coronavirus Disease 2019 (COVID-19) Outbreak in the Republic of Korea from January 19 to March 2, 2020.2020 年 1 月 19 日至 3 月 2 日韩国 2019 年冠状病毒病（COVID-19）疫情的流行病学特征报告。
J Korean Med Sci. 2020 Mar 16;35(10):e112. doi: 10.3346/jkms.2020.35.e112.
7
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
8
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.中国武汉 140 名 SARS-CoV-2 感染患者的临床特征。
Allergy. 2020 Jul;75(7):1730-1741. doi: 10.1111/all.14238. Epub 2020 Feb 27.
9
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.临床证据不支持使用皮质类固醇治疗2019新型冠状病毒肺炎肺损伤。
Lancet. 2020 Feb 15;395(10223):473-475. doi: 10.1016/S0140-6736(20)30317-2. Epub 2020 Feb 7.
10
Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care.加拿大胸科学会慢性阻塞性肺疾病管理建议——2008年更新版——基层医疗要点
Can Respir J. 2008 Jan-Feb;15 Suppl A(Suppl A):1A-8A. doi: 10.1155/2008/641965.